VAERS reports by lot

GSK Varicella/Shingles lot 7F33X: VAERS reports

20 VAERS reports list lot 7F33X as a GSK Varicella/Shingles vaccine, received between 2019-11-01 and 2022-05-20. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
5%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)1427%
Injection-site / Local reaction1224%
Musculoskeletal714%
Neurological510%
Dermatological (non-injection-site)510%
Cardiac / Cardiovascular24%
Allergic / Anaphylactic24%
Thrombotic / Hematological12%
Respiratory12%
Gastrointestinal12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 10).

California7
Washington3
Indiana2
Texas2
New Mexico1
Georgia1
Kansas1
Colorado1
Idaho1
Utah1

Reports by month received

2019-1110
2019-122
2020-011
2020-024
2020-031
2021-011
2022-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.